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F O R E W O R D
There has been a growing interest in the marine derived bioactivecompounds in the recent years, and the functional foods, enriched
with natural ingredients have been proved to provide beneficial action
for human health. Marine derived bioactive components and the functional food ingredients
demonstrated to possess potential health benefits. High value secondary bioactive
metabolites from the marine organisms are attracting attention because of the growing
demand for new compounds of 'marine natural' origin, having potential applications in
pharmaceutical fields, and concerns about the adverse effects by synthetic drugs and their
derivatives. The pioneering R & D works at ICAR-Central Marine Fisheries Research Institute
on marine bioprospecting envisaged a systematic approach involving chemical profiling of
major species of marine organisms for bioactive pharmacophore leads for activity against
various diseases, and a library of molecules with bioactive potential. The research work in
this institute developed protocols to prepare various pharmaceutical leads, nutraceuticals/
functional food supplements enriched with lead molecules with different properties against
various drug targets for use against various life-threatening diseases.
ICAR-Central Marine Fisheries Research Institute is the pioneering marine research
institute in India to work in the frontier area of bioactive molecule discovery from marine
organisms as promising therapeutic agents against various diseases, aquatic food product
technology, and development of high value products for health management. This prestigious
research institute of Indian Council of Agricultural Research is working in the broad national
interest of producing high value bioactive leads from the marine organisms, which would
provide promising therapeutic agents against various diseases. This institute has developed
and commercialized the nutraceutical products CadalminTM Green Algal extract (CadalminTM
GAe) and Antidiabetic extract (CadalminTM ADe) as green alternatives to synthetic drugs to
combat rheumatic arthritic pains and type-2 diabetes, respectively to a leading
biopharmaceutical company in India. The anti-inflammatory nutraceutical Cadalmin™ Green
Mussel extract (Cadalmin™ GMe) from Asian green mussel Perna viridis has been
commercialized with Amalgam Group of Companies. CadalminTM Antihypercholesterolemic
extract (CadalminTM ACe) has been developed from seaweeds to combat dyslipidemia leading
to obesity, and the product was out-licensed to a leading Indian MNC in wellness and
obesity management. Antimicrobial therapeutic product from marine bacteria as oral
applicant has been developed and the product is in pipeline for commercialization. Seaweed-
derived natural template inspired synthetic derivatives as potential pharmacophores were
designed and developed. Several nutraceutical and cosmeceutical products from marine
organisms are in pipeline, and are being commercialized.
The objective of the National level ICAR Winter School on "Recent advances in bioactive
compounds from marine organisms and development of high-value products for health
management" is to provide up-to-date information and acquaint the participants with the
latest technologies on isolation and characterization of marine natural products of
pharmaceutical importance from marine organisms, general and advanced methods of
isolation procedures by chromatography, classification of organic compounds and their
characterization by advanced spectroscopic experiments. This program further aims to give
exposure to the chemical perspectives of marine organisms, primary and secondary bioactive
metabolites from fish and marine organisms to develop bioactive compounds and high-
value functional food products. Theory and practical classes will be conducted in these
areas to provide the participants a hands-on experience.
This ICAR Winter School is organized with the full funding support from ICAR, New
Delhi, and the twenty-five participants from various parts of India who are attending this
programme were selected after scrutiny of their applications based on their bio-data. They
are serving as academicians, such as Professors/Scientists, and in similar posts. The faculties
include the knowledgeable scientists and professors from various parts of India and abroad.
This training will enable the participants to efficiently carry out their academic programmes,
and to plan research on bioactive molecule discovery in their respective laboratories and
institutes so that they can formulate the strategies for research.
The Winter School on "Recent advances in bioactive compounds from marine organisms
and development of high value products for health management" is very ideal for the
current scenario of increasing lifestyle diseases and human health. Understanding the
importance of natural products in the health care system of India, ICAR-Central Marine
Fisheries Research Institute has reasonably contributed in the various aspects. The Manual
released on this occasion covers all aspects of marine natural products prepared by the
experts in their respective fields. I congratulate the Course Director of this programme, Dr.
Kajal Chakraborty and Head of the Marine Biotechnology Division, Dr. P. Vijayagopal, along
with other staff members of Marine Biotechnology Division and Central Marine Fisheries
Research Institute for their sincere efforts in bringing out the manual in time, and to arrange
the programme in a befitting manner.
A. Gopalakrishnan
Director, ICAR-Central Marine Fisheries Research Institute
Kochi, Kerala
P R E F A C E
Marine-derived bioactive components and the functional food ingredients with potentialhealth benefits are an emerging area of research. The rich diversity of flora and fauna
in the marine and coastal habitats of the Indian subcontinent represent an untapped reservoir
of bioactive compounds with valuable pharmaceutical and biomedical use. Considering the
underutilization of these groups of marine organisms, exploring bioactive compounds and
development of any biologically useful products have benefits as health products.
Comprehensive analyses demonstrated that during the last decade the average proportion
of bioactive compounds among the new compounds is declining, though there are a large
number of marine natural products yet to be explored. This may indicate that the research
level of bioactivity is not keeping up with the discovery of new compounds. Thus, the research
tools and methods for finding bioactivity need to be improved. The first improvement is
about methods of spectral and bioactivity-guided separation and purification of marine-
derived secondary metabolites, which combine the discovery of new compounds. These
improvements in technology are dependent upon the automation in spectroscopy, which
also allows the study of the functions of new compounds extracted from the target marine
organisms. Second, for the discovery of new lead compounds and artificial intelligence for
drug development evolved to a more mechanistic approach that targets specific molecular
lesions. Combined with high-throughput screening through a large number of drug targets,
bioactivity research against various life-threatening diseases will be effective in revealing
the potentially useful biological properties of marine natural products. Furthermore, the
discovery of new bioactive compounds from marine metabolites will form the basis for new
drug leads. Thus, the new compounds will absolutely compose an abundant resource for
future bioactivity research and drug development. Various medicinal and biomedical products
from marine flora and fauna provide a myriad of benefits for human health and multiple
life-threatening diseases, and therefore, are the attractive options for the food and
pharmaceutical industry. The increasing interest in marine-based functional food ingredients
and nutraceutical formulations in the last decade along with increased number of patents
filed/granted have appropriately demonstrated the possibilities of bioactive from marine
organisms to maintain and improve human health and well-being.
The present ICAR Winter School on "Recent advances in bioactive compounds from
marine organisms and development of high-value products for health management" is
designed to acquaint the participants with the advances in marine bioactive compounds
with emphasis on the latest technologies on isolation and characterization of marine natural
products of pharmaceutical importance. The course is planned in such a way that it covers
both theoretical and practical aspect of recent advances in bioactive compounds from marine
organisms. This programme will strengthen the knowledge of participants with regard to
the general and advanced methods of isolation procedures by chromatography, and their
characterization by advanced spectroscopic experiments aspects.
I wish to thank the Education Division of Indian Council of Agricultural Research for
giving us an opportunity to organize this ICAR Winter School. We are grateful to Dr. A.
Gopalakrishnan, Director, ICAR-Central Marine Fisheries Research Institute, for his guidance,
continuous interest in the course and providing all necessary facilities. I am highly obliged
to Dr. P. Vijayagopal, Head, Marine Biotechnology Division for his guidance and support for
the programme. All the scientists of Marine Biotechnology Division, technical staff, supporting
staff and research scholars supported us in organizing the ICAR Winter School. I recall with
gratitude the marvellous effort and help in preparing this manual by Minju Joy, Research
Scholar of Marine Biotechnology Division. I take this opportunity to thank all the faculty
members who have devoted their valuable time and contributed material for the preparation
of the manual. I am confident that the Course Manual would aid the participants to enhance
their knowledge and competence in the area of marine bioactive compounds and their
applications for the development of high-value products for health management.
Kajal Chakraborty
January, 2018 Course Director
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Marine natural products: A functional food perspective
The twentieth century has seen significant changes in life styles of world population,
essentially due to rise in purchasing power together with increased leisure and reduced
physical activity. The life style changes had specific impact on food consumption pattern of
general public. There was shift toward consumption of energy dense foods with high levels
of sugar and saturated fats, which during the course of time showed detrimental effects on
health, indicated by rapid global rise in chronic diseases such as obesity, coronary heart
diseases, diabetes, hypertension and rheumatoid arthritis (WHO, 2004; Clydesdale, 2004). It
has been calculated that, in 2001, these diseases contributed approximately 60% of the
56.5million total reported deaths in the world (WHO, 2003). As a consequence, public
recognized the importance of both macro and micronutrients in food in maintenance of
health, which also made them to return to natural foods and there has also been an increasing
demand for functional foods and food supplements, especially from marine products.
MARINE PRODUCTS AS FUNCTIONAL FOODS AND NUTRACEUTICALS
Marine ecosystems have a high diversity of living organisms compared to terrestrial
ecosystems providing numerous resources for human nutrition and health (Hill et al., 2010).
Marine invertebrates are a diverse group with habitats in all ocean ecosystems, ranging
from the intertidal zone to the deep sea environment. Organisms belonging to marine
invertebrates are composed of different taxonomic groups, which can be classified into
several major phyla, namely, Porifera (sponges), Cnidaria (corals, sea anemones, hydrozoans,
jellyfish), Annelida (Polychaetes, marine worms), Bryozoa (moss animals or sea mats), Mollusca
(oysters, abalone, clams, mussels, squid, cuttlefish, octopuses), Arthropoda (lobsters, crabs,
shrimps, prawns, crayfish), and Echinodermata (sea stars, sea cucumbers, sea urchins) (Thorpe
et al., 2000). This diverse group also includes macro algae, microalgae, bacteria, cyanobacteria,
certain fish species and crustaceans that produce secondary metabolites as an adaptation
to their hostile marine environment. Marine sources have received great attention recently;
research on marine-derived molecules has discovered new bioactive compounds with
important properties increasing their applicability as nutraceuticals in the food and
supplement industries. Numerous molecules with biomedical functions are also supplied
by marine ecosystems and are used as pharmaceuticals.
For a marine product to get acceptability, two important criteria need to be satisfied,
namely, its sensory and nutritional properties. The functional value of any food, therefore,
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should be viewed from the point of view of both nutritional functionality and sensory
functionality. The definition of functionality, therefore, differs and from a nutritionist’s point
of view, the functional property is the presence of certain compounds in natural or processed
food that can provide health benefits beyond basic nutrition. However, the food technologist
views functional property as any property of food or food ingredient except its nutritional
ones, which affects its use (Cherry, 1981)
NUTRACEUTICALS: DEFINITION
Nutraceuticals are health promising compounds or products that have been isolated
or purified fromfood sources. The term “nutraceutical”is often used to refer to a food, dietary
supplement, or biologically active compound that provides health benefits. A nutraceutical
is defined as any substance that may be considered as food or part of food and provides
medical or health benefits including the prevention and treatment of diseases. The term
was coined in 1989 by the Foundation of Innovation of Medicine, New York. Nutraceutical
may range from, isolated nutrients, dietary supplements, and diets to genetically engineered
“designer” foods and herbal products.Examples are flavonoids isolated fromSoybean, fish
oil capsules, herbal extracts, glucosamine, chondroitin sulfate, lutein- containing multivitamin
tablets, and antihypertensive pills that contain fish protein derived peptides. These ingredients
are not identified as essential nutrients, but are considered as bioactive substances with
health benefit.Nutraceuticals are nonspecific biological therapies used to promote wellness,
prevent malignant processes, and control symptoms. Phytochemicals and antioxidants are
two specific types of nutraceuticals.There are multiple different types of products that come
under nutraceuticals: Dietary supplements, Functional foods, Medical foods.
FUNCTIONAL FOOD: DEFINITION
The term “functional food” was coined in Japan in mid 1980s to describe processed
foods that contain ingredients such as, oligosaccharides, minerals, polyunsaturated fatty
acids, and fibers that address diseases such as hypertension, in addition to bring nutrition
(Arai, 1996). A food can be regarded as functional if it is satisfactorily demonstrated to
beneficially affect one or more target functions in the body, beyond adequate nutritional
effects, in a way that is relevant to either improved health or well-being and to a reduction
in the risk of disease. According to recent data, a functional food must remain food and it
must demonstrate its effects in amounts that can normally be expected to be consumed in
the diet.It is not a pill or a capsule, but part of the normal food pattern (Tsau, 2005). The U.S.
Institute of Food Technologists Expert Panel defines functional food as food and food
components that provide health benefit beyond basic nutrition. These foods provide essential
nutrients often beyond qualities necessary for normal maintenance, growth, development,
and the biologically active compounds that impart health benefit or desirable physiological
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effects (Hasler, 1998.). The Institute of Medicine of U.S. National Academy of Science has
defined functional foods as foods to which “one or more ingredients have been manipulated
or modified to enhance their contribution to a healthful diet”. From a European point of
view, a food may be considered as functional if it contains a component with a selective
effect of one or various biological functions, whose positive effects justify that it can be
regarded as functional (physiological) or even healthy.
WHAT ARE NUTRACEUTICALS AND HOW THEY ARE DIFFERENT FROM DRUGS?
The term “nutraceutical” was coined by Dr. Stephen DeFelice, founder and chairman of
the Foundation for Innovation in Medicine.  He defined nutraceutical as “...any  substance
that  is  a  food  or  a  part  of  a  food  and  provides  medical  or  health  benefits, including
the prevention and treatment of disease”. Nutraceutical has been defined as “concentrated,
isolated, or purified” pharmacologically bioactive molecules. Nutraceuticals are clearly not
drugs, and unlike synthetic drugs, the potential pharmacologically active substances are
derived from natural sources, and are concentrated by using green extraction/purification
techniques. The purification process eliminates the unnecessary components in the product,
and increases the quantities of the intended pharmacophor(s), which are specifically active
against a particular disease. This apparently leads to greater pharmacological activities of
the nutraceutical products, while maintaining the mean lethal dose (LD50) greater than the
threshold limits that indicate the safety of the products. The LD50 of the nutraceutical products
developed by ICAR-Central Marine Fisheries Research Institute were found to be greater
than 4000 mg/kg body weight of the mammalian subjects that indicate safety of products.
Since early 2000s, world has viewed the extensive growth of the billion dollar nutraceutical
industry, and nutraceuticals are the preferred product portfolio of the leading pharmaceutical
companies in India and abroad. The nutraceuticals portray a distinctive intersection of
pharmaceutical and food products, and will continue to have great attraction because they
are naturally derived concentrated pharmacologically active compound(s), and therefore
are intended to function as “Natural Drug”. The greatest challenge remains to formulate
regulatory guidelines to enable physicians to prescribe this group of specialized medicines,
and will encourage research and development of this group of products.
SOURCES OF MARINE FUNCTIONAL FOOD INGREDIENTS
Marine resources are a source of high value-added compounds with nutraceutical value
to be used as functional ingredients: omega-3 oils, chitin, chitosan, ûsh protein hydrolysates,
algal constituents, carotenoids, collagen, taurine and other bioactive compounds (Kadam
and Prabhasankar, 2010). Chitin and chitosan are polysaccharides, which are gaining much
attention. Fish protein hydrolyzates are enzyme hydrolysis products of ûsh proteins. Algae
and seaweed have been found to be good source of dietary ûbre and antioxidants and
Recent advances in bioactive compounds from marine organisms and development of high value products
Marine natural products: A functional food perspective
17
carotenoids on other hand ûsh bone and shark cartilage are extensively used as source of
calcium. As people become increasingly aware of the relation between diet and good health,
the consumption of ûshery products will most likely increase. They are perceived as an
excellent source of high quality protein, containing lipids with high levels of unsaturated
fatty acids, and perhaps contributing to the enhancement of human health by reducing the
risk of cardiovascular disease. Likewise, seafood is characteristically tender, easily digested,
and a good source of many important minerals. Marine food sources have found enormous
compounds, which are good for health and are having neutraceutical value.
ALGAE
Algae, in particular, edible algae sometimes referred as seaweeds, are a very interesting
natural source of compounds with biological activity, that may be used as functional
ingredients, and considering their great taxonomic diversity, research on identiûcation of
biologically active compounds from algae can be seen as an almost unlimited source.
Moreover, such extracts are virtually fat and calorie-free, making them increasingly sought
for commercial purposes. Macroalgae, i.e. Sargassum species, have been found to be good
sources of dietary ûber and carotenoids with antioxidant activity and play important roles
in the prevention of neurodegenerative diseases (Chandini et al., 2008; Je et al., 2009; Kadam
and Prabhasankar, 2010). Food reserves of brown algae are typically complex polysaccharides
and higher alcohols; many bioactive metabolites have been isolated from the sea-algae
with different pharmacological activities such as cytotoxic, antitumor, nematocidal, antifungal,
anti-inûammatory and antioxidant (Gamal, 2010; Je et al., 2009). Algins, carrageenans and
agar are examples of polysaccharides derived from algae that are widely used as thickeners
and stabilizers in foods as well as for gels (Rasmussen and Morrissey, 2007). Sulphatedfucans,
such as fucoidans from brown algae, carrageenans from red algae and ulvans from green
algae, have been known to act as modulators of coagulation as well as reveal antithrombotic,
anti-inûammatory, antioxidant, anticancer and antidiabetic activities, among others (Pomin,
2009).
MICROALGAE
Microalgae are considered important producers of some highly bioactive compounds
found in marine resources; they can be used to improve food nutritional proûle due to their
richness in PUFAs and pigments such as carotenoids and chlorophylls (Gamal,
2010).Microalgae can be used to enhance the nutritional value of food and animal feed,
they play a crucial role in aquaculture and they can be incorporated into cosmetics (Spolaore
et al., 2006). Microalgae are also rich in pigmentslike chlorophyll (0.5% to 1% of dry weight),
carotenoids (0.1% to 0.2% of dryweight on average and up to 14% of dry weight for â-
caroteneofDunaliella) and phycobiliproteins.
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MARINE FISH
Fish and ûsh wastes are known sources of bioactive ingredients: i) calcium from ûsh
bones; ii) ûsh oils rich in PUFAs from ûsh livers; iii) protein hydrolysates of high biological
value, peptides with antihypertensive activity and aminoacids, such as taurine, which have
antioxidant activity and positive effects on cardiovascular system, from ûsh proteins; iv)
vitamins, antioxidants and minerals (Guerard et al., 2010; Kadam and Prabhasankar, 2010).
Fish occupy the highest position in marine animal consumption and are important to the
world economy. In 2012 fish provided approximately 16% of the world’s protein requirements
with herring, salmon, cod, flounder, tuna, mullet and anchovy being the most common
species of fish used for food (Kim et al., 2012). One of the largest commercially canned
fishery products in the world is tuna. According toFAO of United Nations (2010), the total
catch of the commercial tuna species increased from 162,980 metric tons in 1950 to more
than 4.2 million metric tons in 2007 (Herpandi et al.,2011). The nutritional benefits of fish
consumption are due to the presence of proteins, unsaturated essential fatty acids, minerals
(for example, calcium, iron, selenium and zinc), and vitamins, namely Vitamin A, B3, B6, B12,
E and D. Research has also shown that peptides derived from fermented fish following
enzymatic treatment may be useful therapeutics for the treatment of many common acute
and chronic diseases such as viral infections, cancer and Alzheimer’s disease (Vo et al., 2010
; Wijesekara et al., 2010).
MARINE INVERTEBRATES
Marine invertebrates, like sponges, molluscs, echinoderms and crustaceans, are sources
of bioactive peptides, steroids, terpenoids, strigolactones, alkaloids, ether and phenols (Hu
et al., 2011). Extracts or compounds isolated from marine invertebrates are known to include
antibacterial, antiviral, anthelmintic, antifungal, antihypertensive, and anticancer and have
immune modulatory properties. A great deal of research has been conducted on these
molecules particularly for the development of many new therapeutic agents (Mayeret al.,
2009).
SPONGES
Sponges are sessile metazoans that consist of a gelatinous material, mesophyl, and are
simplest form of multicellular animals. Their hollow pitcher-like body is reinforced by spicules
(a needle-like silica/calcium structure) and spongia (collagen fibers) (Uriz et al., 2003).
Chemically-diverse compounds like alkaloids, terpenoids, polyketides, macrolides,
polyphenolic compounds, peptides and sterols are isolated from sponges with potential to
cure various ailments (Thoms et al., 2007).
Recent advances in bioactive compounds from marine organisms and development of high value products
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MOLLUSCS, ECHINODERMS AND CRUSTACEANS
Molluscs, together with echinoderms, have been widely consumed as marine foods
and are considered natural functional foods. Extensive research has been performed on
bioactive molecules from these sources revealing many significant findings. Bioactive
peptides obtained from the fermented blue mussel and oyster sauces significantly decrease
hypertension (Wijesekara et al., 2010) whilst ground abalone and its shells are used for
treating eye diseases (Kim et al., 2012). Many Asian populations consume cuttlefish, squid,
octopus and nautiloids due to their therapeutic effects, for example rickets are cured with
the bones of cuttlefish, as well as gastrointestinal disorders and ear inflammation (Kim et
al., 2012). Crustaceans are the biggest and most economically important class of marine
arthropods in the global fisheries markets; they also have significant roles in nutraceutical
industries (Kim et al., 2010). In particular, crabs, prawns and shrimps have gained great
attention due to their effective utilization and health benefits (Smith et al., 2010). Nutrient
composition of marine crustaceans like shrimp and krill was analyzed and found to decrease
the total blood lipids in humans, and improve Vitamin A levels, specific proteins, and
eicosapentaenoic acid, omega-3 fatty acids.
MARINE BACTERIA AND FUNGI
Marine bacteria and fungi are being considered as new sources for marine natural
products (Duarte et al.,2012;Imhoffet al.,2011).Marine fungi (yeasts) with high concentration
of ã-amino-butyric acid (GABA), a promising functional and healthy food ingredient, has
been reported by Masuda et al., (2008).Marine extremeophylic bacteria are also of particular
interest since they have metabolic pathways adapted to various extreme marine
environments; the extremophiles are still a huge source of unknown and uncultivated bacteria;
many microbial exopolysaccharides and enzymes from extremophiles have potential and
unique properties (Laurienzo, 2010). Diatoms are also particular organisms that besides
being photosynthetically robust organisms with a high degree of ûexibility to adapt to
different environments (from the Equator to the Ice sea), which is of interest for
biotechnological applications, they are able to produce substances for functional foods
(Bozarthetal., 2009); the most relevant functional ingredients are PUFAs such as EPA, ARA,
DHA and other omega-3 fatty acids.
MARINE FUNCTIONAL FOOD INGREDIENTS
Marine ecosystems provide a diverse range of bioactive molecules with extensive
applications as nutraceuticals in the food and supplement industries. These bioactive
molecules can be proteins, peptides, polysaccharides, fatty acids, polyphenols, probiotics,
enzymes, vitamins and minerals. The remaining sections of this review discuss the physical
and chemical properties of these different molecules and how they contribute bioactivity in
the context of nutraceutical applications.
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PROTEINS
Proteins from marine sources including fish (cod, tuna, herring, rout, hake, and haddock),
crustaceans, molluscs, extremophiles like Dunaliella, and seaweeds have unique properties
such as gel-formation, film and foaming capacity, antioxidant, anticoagulant and antimicrobial
activity.  For example, collagen, gelatin and albumin are common marine proteins used in
foods and are enzymatically hydrolyzed for the production of bioactive peptides which may
have the potential to be used as nutraceuticals. The marine protein protamine is also used
as a natural antibacterial preservative in the food industry.
PEPTIDES
Bioactive peptides are protein fragments ranging in size from 2-20 amino acid residues
that may be generated from parent proteins during digestion or processing (Di-Bernardini
et al., 2011). Two factors can influence the type of bioactive peptides produced: (1) the
primary sequence of the protein substrate; and (2) the specificity of the enzyme(s) used to
generate such peptides. Furthermore, bioactive peptides can be generated from proteins
using hydrolysis (acid or alkaline), cooking or fermentation. These peptides have a range of
bioactivities including antimicrobial, immunomodulatory, antithrombotic, and
antihypertensive activity (Murrayet al., 2007). They are considered highly significant
compounds. Research is being performed to understand peptide structure, composition
and sequences. Bioactive peptides have various regulatory functions on specific cellular
target formulations (Agyei et al., 2011). Many researchers have focused on the development
of pharmaceutical compounds from marine-derived peptides particularly for ACE inhibition
and antihypertensive function (Byun, et al., 2001). Marine proteins from fish, molluscs and
crustaceans are amongst the richest sources of bioactive molecules (Rajapakse, 2005).
Collagen is a valuable part of bovine and porcine meat and is used in different industries
like cosmetics, pharmaceutics, food and biomedicine.Meat collagen is an excellent source
of bioactive peptides that function as antihypertensives and antithrombotics as well as
inhibitors of brush border enzymes like dipeptidyl peptidase-IV (Minkiewicz, et al., 2011).
FATTY ACID
Marine fish species and algae have been identified as sources of polyunsaturated fatty
acids which are rich in ù-3 or ù-6 fatty acids. The presence of these unsaturated fatty acids
in marine-derived foods increases their applicability as nutraceuticals in the food industry
(Harris et al., 2010). Marine-based nutraceuticals have many unique features not found in
nutraceuticals obtained from terrestrial resources, and this is one of the reasons why they
are gaining more attention. The most common sources of marine oils are fungi
(Phycomycetes), fish (salmon, tuna, sardines, and herring), microalgae, extremophiles,
macroalgae (Bryophyta, Rhodophyta) and krill. Consumption of marine oils provides
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numerous health benefits like visual and neurodevelopment, amelioration of diseases such
as hypertension and arthritis and a reduced risk of cardiovascular problems (Sijtsma, 2004).
PHENOLIC COMPOUNDS AND PREBIOTICS
Phenolic compounds found in marine algae are known mainly as a mechanism of
adaptation for oxidative stress (Shibata et al., 2008). Usually phlorotannins are the most
abundant polyphenols found in the marine brown algae whereas flavonoids contribute
most to the total phenolic content in green algae. The brown algal phlorotannin profile
mainly consists of phloroglucinol, eckol, and dieckol(Shibata et al., 2008). Antioxidant activity
has also been reported from phlorotannins enabling these phenolic compounds to be used
as active ingredients in nutraceuticals(Arct et al., 2008). Similar to polyphenols, carotenoids,
synthesized in certain marine bacteria and algal species, also have antioxidant properties
which increase their applicability as nutraceuticals. Carotenoids are lipid-soluble, natural
pigments with 40-carbon structures(Lee et al., 2007). Different carotenoids are synthesized
within the marine organisms, for example, â-carotene, astaxanthin and fucoxanthin are known
to have a high antioxidant capacity. Antioxidants have protective roles against excess reactive
oxygen species, and also act against oxidative rancidity and peroxidation products like
superoxide anions, hydroxyl radicals and hydrogen peroxide that cause deterioration of
foods. Currently, commercial preparation of â-carotene and astaxanthin is available using
Dunaliella species and Haematococcus species, respectively (Vidanarachchi et al., 2011.)
Prebiotics are non-digestible, selectively-fermented compounds that stimulate the growth
and activity of beneficial gut microbiota which, in turn, confer a health benefit to the host.
Usually, prebiotics are oligosaccharides such as chitosan oligosaccharides, while certain
other algal polysaccharides have prebiotic activity(Sullivan et al., 2010). Bifidogenic benefits
have been reported from exopolysaccharides produced by marine lactic acid bacteria
(Honypattarakere, et al., 2012). Further, the cyanobacterial biomass of Spirulinaplatensis is
able to stimulate both Lactobacillus and Bifidobacterium, promoting their prebiotic effect.
Photosynthetic pigments are obtained from red and blue-green algae, aquatic plants,
microalgae and seaweed. These pigments provide nutraceuticals, natural food coloring,
anti-inflammatory, anticarcinogenic, antioxidant compounds (Ramirez et al., 2003).
ENZYMES, VITAMINS AND MINERALS
Enzymes have the ability to change other molecules into valuable biotechnological
tools that can be used in food and nutraceutical industries. As food ingredients, enzymes
can influence factors such as spoilage, storage, processing and safety. Enzymes derived
from marine sources are lipase, chitinolytic enzymes, polyphenol oxidase (Catecholase,
tyrosinase, cresolase, polyphenolase, catechol oxidase, phendase), and transglutamase, and
red algal enzymes involved in a starch degradation pathway (for eg. á-1,4-glucanase). They
have excellent chemical, physical and/or catalytic properties compared with their terrestrial
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counterparts. They also have the ability to be inactivated at moderate temperatures and
show high catalytic activity when the temperature is low (Diaz-Lopez et al., 2000). Additionally
these enzymes are used as food ingredients. They are used in food processing due to their
salt tolerance, specificity, diverse properties and high activity at mild pH (Okada et al.,
2007). Biomolecules such as enzymes isolated from extremophiles can be highly useful in
the food industry due to their unique activities under abnormal conditions, and it has been
widely accepted that extremophiles have strong potential to be valuable resources for use
in biotechnology (Fujiwara et al., 2002). Vitamins and minerals perform many essential
functions in the body, for example, they provide transport inside cells and also serve as
cofactors during metabolic processes. Seaweeds are rich sources of vitamins and minerals
including iron, iodine, manganese and zinc (Parr et al., 2006). Some types of seaweed could
be used as natural sources of iodine (Pena-Rodriguez et al., 2011).Marine ûsh oils are rich
sources of vitamins A, D, and E. Vitamin A is concentrated mostly in ûsh liver oils. Halibut
and cod liver oils are rich sources of vitamins A and D. Sardine ûsh contains up to 4500 IU of
vitamin A and up to 500 IU of vitamin D per 100 g of meat, with an average of 125 ìg/g of oil.
OMEGA-3 FATTY ACIDS
Omega-3 oils are incorporated in bakery products, pastas, dairy products such as milk,
yogurt and juice as well as nutrition bars. Novel microencapsulated oil prepared by Ocean
Nutrition Canada, known as MEG 3 remains protected from environment until it reaches the
gastro intestinal tract (Young and Conquer,2008).A study by Conquer and Holub (1998)
showed that DHA supplementation in humans increased serum DHA as non-esteriûed fatty
acid at levels that were potentially antithrombotic. Liu, Wallin, and Saldeen (2001) found a
signiûcant increase in plasma omega-3 fatty acids and in HDL-cholesterol in 36 hyper
lipidemic patients fed with bread containing ûsh oil. Park, Choi, and Kim (2000) reported
that ûsh oil had a protective effect against cardiovascular disease by inhibiting hepatic
HMGCo- A reductase activity and increasing hepatic microsomal ûuidity, leading to a
reduction in plasma lipids. The ability of ù-3 polyunsaturated fatty acids to modulate tumor-
cell growth was demonstrated for EPA by Chiuand Wan (1999). They showed EPA arrested
cell-cycle progression at G0/G1 phase, inducing necrosis in human leukemic HL-60 and K-
562 cells in vitro. EPA, however, only induced apoptosis in HL-60 cells by down regulation of
Bcl-2. Consequently, PUFAs and their derivatives and analogues are important neutraceutical
and pharmaceutical targets (Ward and Singh, 2005). Omega fatty acids have potential
application in health promotion; prevention from atherosclerosis, protection against
arrhythmias, reduce blood pressure, beneûcial for diabetic patients, ûght against manic-
depressive illness, reduce symptoms in asthma patients, protection against chronic
obstructive pulmonary diseases, alleviation of symptoms of cystic ûbrosis, prevent various
cancers, provide bone health, and improve brain functions in children.
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CHITIN
Chitin, second most abundant natural polymer, is extractable from crustaceans
(Honorkarand Barikani, 2009). Chitosan, a chitin derivative resulting from processing shells
and bones from crab, shrimp, cuttleûsh, etc., is a biodegradable and biocompatible polymer
with antibacterial activity which can be used as a food preservative. Biological activities of
chitosan and chito-oligosac charides (hypocholesterolemic, antimicrobial, immunity
enhancing, antitumor, anticancer, antioxidant, etc.) and the potential application in food,
among other applications are reviewed by Xia et al., (2011). Chitin and chitosan polymers
have unique structures properties, highly sophisticated functions and wide ranging
applications in variety of ûelds such as agricultural, chemistry, medicine, biotechnology, the
pulp and paper industry, cosmetics, water treatment and foods (Chandy and
Sharma,1990).Chitosan is approved for use as a food additive or dietary supplement in
countries such as Japan, England, USA, Italy, Portugal, and Finland. In 1992, chitosan was
accepted as a functional food ingredient by Japan’s health department. The main producers
of chitosan are Japan and the United states with smaller operations in India, Italy and Poland
(Chen andSubirade, 2005). Chitin and chitosan have a variety of nutraceutical applications,
including immune-enhancement, disease recovery, and use as dietary ûbre. Their ability to
be usefulintheseareasislargelydependentonfactors such as molecular weight and degree of
N-acetylation, which can greatly inûuence solubility and interactions with other biomolecules.
CHLOROPHYLL
Chlorophyll a, phycocyanins, and phycoerythrin are pigments of interest found in
cyanobacteria which are also named as blue-green algae. These microorganisms present a
secondary metabolism that produces several compounds: some are problematic for public
health since they are strong hepatotoxins or neurotoxins whereas others reveal potential
biological activities such as anticancer, antibacterial, antifungal, and immunosuppressive
properties; these have all been reviewed by Gamal(2010).Owing to their rich chemical
composition, which depends on microalgae species, they can be used as a nutritional
supplement or represent a source of food natural colorants as soon as their safety is assured
(Mata et al., 2010; Spolaore et al., 2006).
POLYSACCHARIDES
Algae have mainly been used in western countries as raw material to extract alginates
(from brown algae) and carragenates (from red algae). Algae also contain multitude of
bioactive compounds that might have antioxidant, antibacterial, antiviral and anti-
carcinogenic properties. Consumption of dietary ûbre has a positive inûuence on several
aspects related to health such as reducing the risk of suffering from colon cancer, constipation,
hypercholesterolemia, obesity and diabetes. Besides, many constituents of dietary ûbre
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show antioxidant activity as well as immunological activity (Suzuki et al., 2004). In this sense,
U. pinnatiûda showed some positive effect on cardiovascular diseases (hypertension and
hypercholesterolemia) (Ikeda et al., 2003); this alga contains basically dietetic ûbre, being its
principal component alginate. This alginic acid has demonstrated to reduce hypertension
in hypertensive rates (Ikeda et al., 2003). There are numerous commercial applications of
marine polysaccharides in food, beverages and supplements. Marine polysaccharides,
extracted from algae, crustaceans and other marine organisms include fucans/fucanoids,
carrageenans, hydrocolloids and glycosaminoglycans. These molecules have many biological
functions including antiviral, anticoagulant, antiproliferative, antithrombotic and anti-
inflammatory activity (Berteau et al., 2003). Carrageenans and alginates are linear biopolymers
that have been identified as the most abundant polysaccharides found in red and brown
algae, respectively (Kim, et al., 2008). Apart from alginate, brown algae also contain highly
complex, sulfated matrix polysaccharides called fucoidans. The complex structure of the
fucoidans extracted from different marine species varies in saccharide composition, sulfate
content, and positions of sulfate groups, molecular weight, linkage mode, and sequence of
saccharide residues (Li et al., 2008). Structural sulfate groups improve the biological properties
of fucoidans which enables their application as nutraceuticals in the dairy industry
(Vidanarachchi et al., 2011).
CAROTENOIDS
The carotenoids, found in nature, can be classiûed into two: hydrocarbons, such as â-
carotene, xanthophylls, and the oxygenated derivatives of carotenes such as astacene,
astaxanthin,canthaxanthin, cryptoxanthin, echionine, lutein, neoxanthin, violaxanthin, and
zeaxanthin. Originally of interest for their use as a food colouring agent, and still used as
such, these compounds give some ûsh and shellûsh their reddish pink colour. The two main
carotenoids, astaxanthin and canthaxanthin are extracted from crab and shrimp processing.
Newer uses for both these compounds have been identiûed. Their highly antioxidative
properties make them candidatesasfunctionalfoodingredients.Astaxanthinmayhaveauseasan
anti-aging compound, whilst canthaxanthin could contribute to treatments for Alzheimer’s
and Parkinson’s disease, high cholesterol, strokes and cancer (Miyashita and Hosokawa,
2008). Crabs are important crustaceans, in which carotenoids occur. Astaxanthin and its
esters were found to be the major carotenoids in red kelp crab, Taliepesnuttalli, snow crab
Chinocetesopilio, hermit crab, Paralithodesbrevipes, and blue crab (Sachindra et al., 2005).
Astaxanthin is a very potent antioxidant. Several studies have shown that its activity can be
several folds higher than that of other antioxidants, for example B-carotene and Vitamin E.
The powerful antioxidant activity also can play a role in astaxanthin’senhancement of immune
responses, liver function and eye, joint, prostate, and heart health. It can also be used
incardiovascular health, neurodegenerative diseases and anticancer activity (Olaizola, 2008).
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Wakame (Undariapinnatiûda) is one of the most popular edible seaweed in Japan and has
been found to contain 5-10% fucoxanthin apart from containing polar lipids such as
glycolipids. Health beneûts of fucoxanthin are anticancer effect - it is evaluated that
neoxanthin and fucoxanthin were reported to cause a remarkable reduction in growth of
prostate cancer cells, and also demonstrated antiobesity activity and anti-inûammatory
activity (Miyashita and Hosokawa, 2008). Fucoxanthin is other major biofunctional pigment
of brown seaweeds and the content in various edible seaweeds including U. pinnatiûda has
been reviewed by Hosakawa et al., (2006).
CALCIUM AND FISH BONE
Fish bone is considered as a potential source of calcium. Fish bone material derived
from processing of large ûsh is a useful calcium source. To use ûsh bone as a calcium
fortiûcant, the bone should be converted into an edible form by softening its structure. Fish
bone powder is a potential value-added by-product of the tuna processing industry.The
calcium containing powder from ûsh bone could be used for the fortiûcation of ûsh products
such as surimi (Shungan, 1996).
CONCLUSIONS
Marine products, due to its phenomenal biodiversity, are treasure house of many novel
healthy food ingredients and biologically active compounds such as ûsh oils, ûsh proteins,
and seaweeds. Marine functional ingredients such as ûsh oils, seaweeds and ûsh proteins
have found application productindustry. These are added in the form of fortiûcants and
nutritional enrichments in food. These products have shown considerable improvement in
EPA and DHA contents of breads and other bakery products leading to reduction of
cardiovascular diseases which is major health concern of 21st century.Marine nutraceuticals
are both a coherent and attractive option for the food industry as there are a multitude of
functional food ingredients that can be derived from marine sources. It is also believed that,
as people become increasingly aware of the association between diet and good health, the
consumption of fishery products will most likely increase. Moreover, in relation to marine
algae, their content in proteins, carbohydrates, lipids, fibre, metabolites, etc. can be influenced
by their growing parameters (water temperature, salinity, light and nutrients). This means
that, from a biotechnological perspective, algae can be considered as natural bioreactors,
able to provide different types of compounds at different quantities-an appealing attribute
to the functional food industry. Despite the vast possibilities for use of marine bioactives in
food, more multidisciplinary research is needed. Consequently, ongoing efforts should be
made into the research and development of marine functional foods with prospect that, in
the future, their consumption could lead to a reduction in the prevalence and severity of
chronic diseases. Thus, constant efforts in research and development in the ûeld of marine
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functional food ingredients is needed for the future diet which will help in reducing all
health problems of human beings
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